CD27 synergizes with CD40 to induce IgM, IgG, and IgA antibody responses of peripheral blood B cells in the presence of IL-2 and IL-10

Immunology Letters

Volumn 89, Issue 2-3, 2003, Pages 251-257

  Hirano, Testuo ^a   Yonekubo, Isao ^a   Shimo, Kuniaki ^a   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibody response; CD27; CD40; IL 10; IL 2

Indexed keywords

CD27 ANTIGEN; CD40 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; L CELL; PRIORITY JOURNAL;

EID: 0141527371     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(03)00156-1     Document Type: Article

References (38)

1. Clark E.A., Ledbetter J.A. How B and T cells talk to each other. Nature. 367:1994;425-428.
2. Janeway C.A. Jr., Bottomly K. Signals and signs for lymphocyte responses. Cell. 76:1994;275-285.
3. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:1994;959-962.
4. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104:2001;487-501.
5. Laman J.D., Claassen F., Noelle R.J. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:1996;59-108.
6. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922.
7. Hodgkin P.D., Yamashita L.C., Coffman R.L., Kehry M.R. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immunol. 145:1990;2025-2034.
8. Barrett T.B., Shu G., Clark E.A. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1991;1722-1729.
9. Shapira S.K., Vercelli D., Jabara H.H., Fu S.M., Geha R.S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:1992;289-292.
10. Grammer A.C., Lipsky P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 76:2000;61-178.
11. Banchereau J., de Paoli P., Valle A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 251:1991;70-72.
12. Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:1991;705-710.
13. Fluckiger A.C., Garrone P., Durand I., Galizzi J.P., Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med. 178:1993;1473-1481.
14. Malisan F., Briere F., Bridon J.M., Harindranath N., Mills F.C., Max E.E., Banchereau J., Martinez-Valdez H. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J. Exp. Med. 183:1996;937-947.
15. Fayette J., Dubois B., Vandenabeele S., Bridon J.M., Vanbervliet B., Durand I., Banchereau J., Caux C., Briere F. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185:1997;1909-1918.
16. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., Fanslow W.C., Belmont J., Spriggs M.K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:1993;990-993.
17. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L.S., Stenkamp R., Neubauer M., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:1993;291-300.
18. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 361:1993;541-543.
19. van Lier R.A., Borst J., Vroom T.M., Klein H., Van Mourik P., Zeijlemaker W.P., Melief C.J. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139:1987;1589-1596.
20. Hintzen R.Q., de Jong R., Lens S.M., van Lier R.A. CD27: marker and mediator of T-cell activation? Immunol. Today. 15:1994;307-311.
21. Agematsu K. Memory B cells and CD27. Histol. Histopathol. 15:2000;573-576.
22. Jacquot S. CD27/CD70 interactions regulate T-dependent B cell differentiation. Immunol. Res. 21:2000;23-30.
23. Nagumo H., Agematsu K., Shinozaki K., Hokibara S., Ito S., Takamoto M., Nikaido T., Yasui K., Uehara Y., Yachie A., Komiyama A. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J. Immunol. 161:1998;6496-6502.
24. Kobata T., Jacquot S., Kozlowski S., Agematsu K., Schlossman S.F., Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA. 92:1995;11249-11253.
25. Jacquot S., Kobata T., Iwata S., Morimoto C., Schlossman S.F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J. Immunol. 159:1997;2652-2657.
26. Rasmussen A.M., Smeland E.B., Erikstein B.K., Caignault L., Funderud S. A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods. 146:1992;195-202.
27. Yamaya S., Yamamoto A., Komiya T., Mizuguchi J., Matuhasi T. Preparation of a diphtheria toxin-pullulan conjugate that elicits good IgG antibody production with poor IgE synthesis. Vaccine. 8:1990;65-69.
28. Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:1992;671-682.
29. MacLennan I.C. Germinal centers. Annu. Rev. Immunol. 12:1994;117-139.
30. McHeyzer-Williams L.J., Driver D.J., McHeyzer-Williams M.G. Germinal center reaction. Curr. Opin. Hematol. 8:2001;52-59.
31. Agematsu K., Kobata T., Sugita K., Hirose T., Schlossman S.F., Morimoto C. Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J. Immunol. 154:1995;3627-3635.
32. Billips L.G., Lassoued K., Nunez C., Wang J., Kubagawa H., Gartland G.L., Burrows P.D., Cooper M.D. Human B-cell development. Ann. N.Y. Acad. Sci. 764:1995;1-8.
33. Martinez-Valdez H., Guret C., de Bouteiller O., Fugier I., Banchereau J., Liu Y.J. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J. Exp. Med. 183:1996;971-977.
34. Ghia P., ten Boekel E., Rolink A.G., Melchers F. B-cell development: a comparison between mouse and man. Immunol. Today. 19:1998;480-485.
35. Tangye S.G., Liu Y.J., Aversa G., Phillips J.H., de Vries J.E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1998;1691-1703.
36. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1998;1679-1689.
37. Nagumo H., Agematsu K., Kobayashi N., Shinozaki K., Hokibara S., Nagase H., Takamoto M., Yasui K., Sugane K., Komiyama A. The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells. Blood. 99:2002;567-575.
38. Prasad K.V., Ao Z., Yoon Y., Wu M.X., Rizk M., Jacquot S., Schlossman S.F. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA. 94:1997;6346-6351.